Drug class in one race
IL-33 drugs for Chronic Obstructive Pulmonary Disease
3 tracked IL-33 drugs in the Chronic Obstructive Pulmonary Disease race. The class explanation lives on the IL-33 page; the full indication pipeline across every mechanism is on the Chronic Obstructive Pulmonary Disease page.
2 Phase 31 Phase 1
Head-to-head evidence: GSK3862995 vs itepekimab · GSK3862995 vs tozorakimab · itepekimab vs tozorakimab